Based on Phase 2 studies, the initial dose may begin at 1 mg to 2 mg (0.0750.15 mL) once weekly, with gradual titration every 4 weeks in increments of 2 mg to 4 mg, as tolerated, up to a maximum of 12 mg (0.90 mL) weekly Doses between 4 mg and 12 mg weekly demonstrated meaningful reductions in body weight and glycemic parameters over 16 to 28 weeks
Your options today: clinical trials give you access to the real, pharmaceutical-grade drug under medical supervision
When administered in a clinical setting with pharmaceutical-grade peptides under medical supervision, the risk profile is substantially lower
As with any strong active, it is recommended to start with a lower level and build up your skins tolerance for the ingredient
Most Patients Do Not Simply Walk Away The study, published in the journal Diabetes Obesity and Metabolism, was led by Hamlet Gasoyan, a researcher with Cleveland Clinic's Center for Value-Based Care Research
The solution is clear when ready